Top Buy
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Roche Holding AG ADR | 3 | 3 | 0 | 1 | €37.32 | €38.00 | 1.827% |
| Novo Nordisk A/S ADR | 20 | 1 | 0 | 0 | €117.00 | €144.02 | 23.093% |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 0 | 0 | €24.01 | €54.98 | 128.992% |
| G1 Therapeutics | 20 | 1 | 0 | 0 | €3.65 | €11.03 | 202.103% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €9.25 | €10.00 | 8.108% |
| Akero Therapeutics Inc | 18 | 0 | 0 | 0 | €24.61 | €38.62 | 56.941% |
| Alkermes plc | 17 | 2 | 0 | 0 | €24.40 | €35.01 | 43.497% |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | €345.50 | €418.12 | 21.020% |
| Brainstorm Cell | 2 | 0 | 0 | 0 | €0.29 | €1.84 | 533.448% |
| Stoke Therapeutics Inc | 16 | 1 | 0 | 0 | €13.70 | €20.51 | 49.712% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €252.20 | €315.00 | 24.901% |
| Iovance Biotherapeutics Inc. | 22 | 2 | 0 | 0 | €7.13 | €26.25 | 267.904% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €2.36 | €5.55 | 135.322% |
| Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €2.49 | €4.63 | 85.924% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €175.80 | €182.79 | 3.976% |
| Polynovo Ltd | 1 | 0 | 0 | 0 | €1.50 | - | - |
| XOMA Corp. | 8 | 0 | 0 | 0 | €22.20 | €68.51 | 208.600% |
| Precision BioSciences Inc | 9 | 0 | 0 | 0 | €0.35 | €10.38 | 2881.839% |
| aTyr Pharma Inc | 1 | 0 | 0 | 0 | €1.76 | €10.00 | 468.182% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €18.98 | - | - |
| Achieve Life Sciences Inc. | 1 | 0 | 0 | 0 | €4.43 | - | - |
| Taro Pharmaceutical Industries Ltd | 10 | 0 | 0 | 0 | €40.00 | - | - |
| Kala Pharmaceuticals Inc. | 5 | 0 | 0 | 0 | €5.50 | €19.50 | 254.841% |
| Personalis Inc | 8 | 1 | 0 | 0 | €3.19 | €3.26 | 2.274% |
| Twist Bioscience Corp | 11 | 1 | 0 | 1 | €39.36 | €41.65 | 5.812% |